Wednesday, May 20, 2020 7:48:05 PM
Find Analyst Ratings for:
Date Research Firm Action Current PT
5/19/20 SVB Leerink Maintains Outperform 27.0
2/03/20 Citigroup Reinstates Neutral 15.0
8/28/19 Goldman Sachs Initiates Coverage On Buy 20.0
8/19/19 SVB Leerink Initiates Coverage On Outperform 26.0
5/30/19 Citi Assumes Buy 25.0
4/12/19 Evercore ISI Group Initiates Coverage On Outperform
2/13/19 Barclays Upgrades Overweight 25.0
11/19/18 Citigroup Maintains Buy 42.0
10/26/18 Goldman Sachs Initiates Coverage On Neutral 25.0
9/13/18 JP Morgan Initiates Coverage On Overweight 39.0
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM